Haemoglobin targets: we were wrong, time to move on

[1]  H. Krum,et al.  Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis , 2007, The Lancet.

[2]  R. Steinbrook.  Haemoglobin concentrations in chronic kidney disease , 2006, The Lancet.

[3]  F. Locatelli,et al.  Anemia and cardiovascular risk: the lesson of the CREATE Trial. , 2006, Journal of the American Society of Nephrology : JASN.

[4]  H. Burger,et al.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia. , 2006, The New England journal of medicine.

[5]  Huiman Barnhart,et al.  Correction of anemia with epoetin alfa in chronic kidney disease. , 2006, The New England journal of medicine.

[6]  G. Remuzzi,et al.  Correction of anemia--payoffs and problems. , 2006, The New England journal of medicine.

[7]  J. Craig,et al.  Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. , 2006, The Cochrane database of systematic reviews.

[8]  J. Craig,et al.  Hypothesis versus association: the optimal hemoglobin target debate. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S. Solomon,et al.  Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. , 2005, American heart journal.

[10]  J. Craig,et al.  Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. , 2004, Journal of the American Society of Nephrology : JASN.

[11]  L. Stevens,et al.  Should Hemoglobin be Normalized in Patients with Chronic Kidney Disease? , 2002, Seminars in dialysis.

[12]  J. Ioannidis,et al.  Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. , 1998, American journal of epidemiology.

[13]  A R Nissenson,et al.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. , 1998, The New England journal of medicine.

[14]  L. Arab,et al.  Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  H. Feldman,et al.  Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.